Ken Griffin Novo Nordisk A S Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Novo Nordisk A S stock. As of the latest transaction made, Citadel Advisors LLC holds 1,407,200 shares of NVO stock, worth $158 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
1,407,200
Previous 1,356,200
3.76%
Holding current value
$158 Million
Previous $174 Million
15.35%
% of portfolio
0.04%
Previous 0.03%
Shares
28 transactions
Others Institutions Holding NVO
# of Institutions
1,971Shares Held
320MCall Options Held
5.16MPut Options Held
4.96M-
Jennison Associates LLC21.2MShares$2.38 Billion1.95% of portfolio
-
Morgan Stanley New York, NY14.6MShares$1.64 Billion0.16% of portfolio
-
Bank Of America Corp Charlotte, NC14.2MShares$1.59 Billion0.18% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.4MShares$1.5 Billion0.83% of portfolio
-
Fayez Sarofim & CO Houston, TX12.6MShares$1.41 Billion4.91% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $253B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...